Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 103 | 2 | 103 | +2 |
| Shares | 50.5M | 103.8K | 59.3M | +8.92M (+17.7%) |
| Value | $129.2M | $265.0K | $91.3M | −$37.6M (−29.2%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (24)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Man Group plc | 439,782 | $1.13M |
| Granahan Investment Management Inc | 405,247 | $1.04M |
| Two Sigma Investments, LP | 150,109 | $384.0K |
| 683 Capital Management, LLC | 121,367 | $311.0K |
| Balyasny Asset Management LLC | 109,305 | $280.0K |
| LMR Partners LLP | 107,355 | $275.0K |
| Sciencast Management LP | 35,934 | $92.0K |
| Boothbay Fund Management, LLC | 32,414 | $83.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 28,897 | $74.0K |
| Ergoteles LLC | 25,200 | $65.0K |
| Jump Financial, LLC | 23,100 | $59.0K |
| Old Mission Capital LLC | 21,505 | $55.0K |
| Searle & Co. | 20,000 | $51.0K |
| State of Wyoming | 19,836 | $51.0K |
| Fifth Lane Capital, LP | 17,513 | $45.0K |
| Shay Capital LLC | 13,390 | $34.0K |
| Schonfeld Strategic Advisors LLC | 12,500 | $32.0K |
| CTC Capital Management, LLC | 11,800 | $30.0K |
| TownSquare Capital, LLC | 10,506 | $27.0K |
| Ovata Capital Management Ltd | 2,200 | $6.00K |
| Signaturefd, LLC | 1,445 | $4.00K |
| US Bancorp | 444 | $1.00K |
| Lloyd Advisory Services, LLC. | 329 | $1.00K |
| Federation des caisses Desjardins du Quebec | 300 | $768 |
Not filed for Q2 2022 yet (2)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 66,540 | $170.0K |
| Parametric Portfolio Associates LLC | 37,212 | $95.0K |